Nurul Amalina Abd Aziz

Nurul Amalina Abd Aziz

Faculty of Health Science, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Molecules
Verified
Journal Article
Open access
PDF file
NANurul Amalina Abd Aziz
Nurul Amalina Abd Aziz
NANormah Awang
Normah Awang
KCKok Meng Chan
Kok Meng Chan
NKNurul Farahana Kamaludin
Nurul Farahana Kamaludin
NANur Najmi Mohamad Anuar
Nur Najmi Mohamad Anuar
Organotin (IV) dithiocarbamate has recently received attention as a therapeutic agent among organotin (IV) compounds. The individual properties of the organotin (IV) and dithiocarbamate moieties in the hybrid complex form a synergy of action that stimulates increased biological activity. Organotin (IV) components have been shown to play a crucial role in cytotoxicity. The biological effects of organotin compounds are believed to be influenced by the number of Sn-C bonds and the number and nature of alkyl or aryl substituents within the organotin structure. Ligands target and react with molecules while preventing unwanted changes in the biomolecules. Organotin (IV) dithiocarbamate compounds have also been shown to have a broad range of cellular, biochemical, and molecular effects, with their toxicity largely determined by their structure. Continuing the investigation of the cytotoxicity of organotin (IV) dithiocarbamates, this mini-review delves into the appropriate method for synthesis and discusses the elemental and spectroscopic analyses and potential cytotoxic effects of these compounds from articles published since 2010.

26 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
NANurul Amalina Abd Aziz
Nurul Amalina Abd Aziz
NANormah Awang
Normah Awang
KCKok Meng Chan
Kok Meng Chan
NKNurul Farahana Kamaludin
Nurul Farahana Kamaludin
NANur Najmi Mohamad Anuar
Nur Najmi Mohamad Anuar
After Frankland first synthesized organotin compounds for the first time in 1849, their broad range of applications, including in industry and agriculture, resulted in a substantial increase in demand for organotin (IV) compounds after the 1940s. Because of the broad range of coordination numbers and molecular geometry that could result in numerous features, the structural diversity of organotin (IV) compounds is of great interest. Organotin (IV) dithiocarbamate has recently received attention as a therapeutic agent among organotin (IV) compounds. The hybrid complex individual properties of organotin (IV) and the dithiocarbamate moieties form a synergy of action stimulating increased biological activity. Organotin (IV) components have been shown in cytotoxicity studies to play a crucial role in cytotoxicity. Ligands serve to target and react to molecules while preventing unwanted changes in biomolecules. Organotin (IV) dithiocarbamate compounds have also been discovered to exhibit a broad range of cellular, biochemical, and molecular effects, with their toxicity largely determined by their structure. This review discusses the potential cytotoxicity effect of organotin(IV) dithiocarbamate, as well as its synthesis, elemental and spectroscopy analysis.

24 October 2022 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
PDF file
NANurul Amalina Abd Aziz
Nurul Amalina Abd Aziz
NANormah Awang
Normah Awang
KCKok Meng Chan
Kok Meng Chan
NKNurul Farahana Kamaludin
Nurul Farahana Kamaludin
NANur Najmi Mohamad Anuar
Nur Najmi Mohamad Anuar
Edward Richard Tom TiekinkEdward Richard Tom Tiekink
Edward Richard Tom Tiekink
C26H38N2S4Sn, triclinic, P 1 ‾ (no. 2), a = 9.6272(1) Å, b = 12.1043(2) Å, c = 13.3584(2) Å, α = 82.296(1)°, β = 86.611(1)°, γ = 66.912(1)°, V = 1419.02(4) Å3, Z = 2, Rgt(F) = 0.0235, wRref(F2) = 0.0612, T = 100 K.